Studies have shown that downregulation of LRIG1 (leucine-rich repeat and immunoglobulin-like domain containing) enhanced EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling, promoting malignant behaviors of cancer cells [9, 10]. Here, SPHK1 is linked to cancer.